🚀 Apply for £10k+ grants with our Startup Launch Kit
shadow shadow shadow shadow shadow
    Country
    Opportunity Status
    Funding Instrument Type
    Category
    Clear

    PEP Packs: Postexposure Prophylaxis Packs for Immediate Access to HIV and Sexually Transmitted Infection Prevention

    RFA-PS-25-112

    Amy Yang

    Opening date 6 Aug 2024, 12:00AM

    Closing date N/A

    Funding Opportunity Number: RFA-PS-25-112

    Opportunity Category: Discretionary

    Expected Number of Awards: 1

    CFDA Number(s): 93.084 -- Prevention of Disease, Disability, and Death by Infectious Diseases

    Cost Sharing or Matching Requirement: No

    Posted Date: Aug 06, 2024 12:00:00 AM EDT

    Closing Date: N/A

    Estimated Total Program Funding: 4800000

    Award Ceiling: $1200000

    Award Floor: $900000

    Eligible Applicants: Private institutions of higher education,City or township governments,Public housing authorities/Indian housing authorities,County governments,Native American tribal governments (Federally recognized),Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education,Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education,Special district governments,Native American tribal organizations (other than Federally recognized tribal governments),Independent school districts,Public and State controlled institutions of higher education,For profit organizations other than small businesses,State governments

    Description: The purpose of this notice of funding opportunity (NOFO) is to support an implementation research study. In this study, optimal strategies will be assessed for a postexposure prophylaxis (PEP) in pocket (PiP) approach for prevention of HIV and sexually transmitted infections (STIs) among gay, bisexual, and other men who have sex with men (MSM) and transgender women (TGW). The recipient will implement and evaluate a comprehensive strategy to integrate PEP packs as a component of existing PrEP and STI clinical services. PEP packs will include a supply of antiretroviral medication for nonoccupational PEP (nPEP), doxycycline for STI PEP (DoxyPEP), HIV and STI self-test kits, and instruction materials. Study clinics should be in communities with high rates of HIV diagnoses among disproportionately affected populations, especially Black and Hispanic MSM and TGW.

    We use cookies and similar technologies that are necessary to operate the website.Please read our cookie policy.

    We use cookies and similar technologies that are necessary to operate the website. Additional cookies are only used with your consent. We use the additional cookies to perform analyses of website usage and to check marketing measures for their efficiency. These analyses are carried out to provide you with a better user experience on the website. You are free to give, deny, or withdraw your consent at any time by using the "cookie settings" link at the bottom of each page. You can consent to our use of cookies by clicking "Agree". For more information about what information is collected and how it is shared with our partners, please read our cookie policy.

    • Required to run the website
    • Monitoring website usage and optimizing the user experience
    • Evaluation of marketing actions
    • Storage of your preferences from previous visits
    • Collecting user feedback to improve our website
    • Recording of your interests in order to provide customised content and offers
    Cookie Settings Accept